Please assess the completion status of the following clinical trial:

Trial Title: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
This study collects safety data on patient treatments performed commercially under the FDA approved labeling.~* Eligibility is as per approved device indication.~* All registry-consented patients who undergo commercial ExAblate procedure for bone mets palliation after device approval.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).